feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan",https://benzinga.com/general/biotech/22/03/25986838/the-daily-biotech-pulse-ocugen-faces-regulatory-setback-vtv-ceo-quits-biogen-eisai-make-headway-w,https://bit.ly/3ClOdUE
